$220,000 of ACCENTURE FEDERAL SERVICES LLC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"FY26 Approps/ report language for key programs Army/ Air Force/ DOD IT/ logistics modernization; Cybersecurity FAFSA/ FSA/ student loan IT modernization Govt Efficiency/ IT modernization Healthcare IT modernization IRS/ Treasury IT modernization; Legacy IT modernization IT modernization/ Digital GI bill USDA/ Farmers.gov IT modernization Artificial Intelligence; Cybersecurity; Data Analytics; Legacy systems modernization"
You can find more data on corporate lobbying on Quiver Quantitative.
ACN Congressional Stock Trading
Members of Congress have traded $ACN stock 13 times in the past 6 months. Of those trades, 3 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 04/08, 01/13.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/31.
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
- REPRESENTATIVE JULIE JOHNSON has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 03/19, 03/14, 03/12, 03/03.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 02/24.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/13.
- REPRESENTATIVE WILLIAM R. KEATING purchased up to $15,000 on 02/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ACN Insider Trading Activity
ACN insiders have traded $ACN stock on the open market 80 times in the past 6 months. Of those trades, 0 have been purchases and 80 have been sales.
Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:
- JULIE SPELLMAN SWEET (Chair and CEO) has made 0 purchases and 15 sales selling 13,574 shares for an estimated $4,996,935.
- JOEL UNRUCH (General Counsel/Corp Secretary) has made 0 purchases and 10 sales selling 8,313 shares for an estimated $2,727,154.
- JOHN F WALSH (Chief Operating Officer) has made 0 purchases and 5 sales selling 5,000 shares for an estimated $1,715,219.
- MANISH SHARMA (CEO-The Americas) has made 0 purchases and 13 sales selling 4,655 shares for an estimated $1,665,451.
- RYOJI SEKIDO (Co-CEO Asia Pacific) has made 0 purchases and 5 sales selling 1,700 shares for an estimated $670,429.
- MAURO MACCHI (Chief Executive Officer-EMEA) has made 0 purchases and 9 sales selling 2,000 shares for an estimated $646,289.
- ANGIE Y PARK (Chief Financial Officer) has made 0 purchases and 4 sales selling 1,935 shares for an estimated $620,703.
- MELISSA A BURGUM (Chief Accounting Officer) has made 0 purchases and 11 sales selling 1,719 shares for an estimated $618,713.
- ANGELA BEATTY (Chief Leadership & HR Officer) has made 0 purchases and 8 sales selling 1,130 shares for an estimated $388,283.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACN Hedge Fund Activity
We have seen 1,030 institutional investors add shares of ACN stock to their portfolio, and 1,206 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC added 3,624,404 shares (+123.4%) to their portfolio in Q1 2025, for an estimated $1,130,959,024
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,490,569 shares (+63.9%) to their portfolio in Q1 2025, for an estimated $1,089,197,150
- VANGUARD GROUP INC added 3,419,577 shares (+5.7%) to their portfolio in Q1 2025, for an estimated $1,067,044,807
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,944,935 shares (-24.0%) from their portfolio in Q1 2025, for an estimated $918,937,517
- BLACKROCK, INC. added 1,869,722 shares (+3.6%) to their portfolio in Q1 2025, for an estimated $583,428,052
- PACER ADVISORS, INC. added 1,395,135 shares (+2782.1%) to their portfolio in Q1 2025, for an estimated $435,337,925
- CAPITAL INTERNATIONAL INVESTORS removed 1,384,108 shares (-16.3%) from their portfolio in Q1 2025, for an estimated $431,897,060
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACN Analyst Ratings
Wall Street analysts have issued reports on $ACN in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 06/24/2025
- Guggenheim issued a "Buy" rating on 06/23/2025
- Barclays issued a "Overweight" rating on 06/23/2025
- JP Morgan issued a "Overweight" rating on 06/16/2025
- UBS issued a "Buy" rating on 05/22/2025
- Piper Sandler issued a "Overweight" rating on 04/16/2025
- RBC Capital issued a "Outperform" rating on 03/21/2025
To track analyst ratings and price targets for ACN, check out Quiver Quantitative's $ACN forecast page.
ACN Price Targets
Multiple analysts have issued price targets for $ACN recently. We have seen 12 analysts offer price targets for $ACN in the last 6 months, with a median target of $355.0.
Here are some recent targets:
- James Faucette from Morgan Stanley set a target price of $325.0 on 06/24/2025
- Dan Dolev from Mizuho set a target price of $348.0 on 06/24/2025
- Jonathan Lee from Guggenheim set a target price of $335.0 on 06/23/2025
- Ramsey El-Assal from Barclays set a target price of $360.0 on 06/23/2025
- Keith Bachman from BMO Capital set a target price of $325.0 on 06/23/2025
- Tien-Tsin Huang from JP Morgan set a target price of $353.0 on 06/16/2025
- Kevin Mcveigh from UBS set a target price of $395.0 on 05/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
